| 2021 | | Effect of omalizumab as add-on therapy to quality of life questionnaire for korean asthmatics (Kaqlq) in korean patients with severe persistent allergic asthma | 박해심 |
| 2010 | | Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. | 박해심 |
| 2021 | | Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease | 박해심, 신유섭, 최영우 |
| 2011 | | Effect of Toll-like receptor 4 gene polymorphisms on work-related respiratory symptoms and sensitization to wheat flour in bakery workers. | 김승현, 박해심 |
| 2022 | | Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics | 박래웅, 박해심, 이영수, 장재혁 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2017 | | Effects of Immunoglobulin Replacement on Asthma Exacerbation in Adult Asthmatics with IgG Subclass Deficiency | 박해심, 반가영, 신유섭, 예영민 |
| 2015 | | Effects of Intramuscular Injection of Autologous Immunoglobulin on Clinical Severity and Serum IgE Concentration in Patients with Atopic Dermatitis. | 남동호 |
| 2015 | | Effects of MBL2 polymorphisms in patients with diisocyanate-induced occupational asthma. | 김승현, 박해심, 예영민 |
| 2012 | | Effects of omalizumab treatment in patients with refractory chronic urticaria | 박해심, 신유섭, 예영민 |
| 2020 | | Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial | 박주헌, 박해심, 신유섭, 예영민, 우성대, 이영수 |
| 2019 | | Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma | 박해심 |
| 2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
| 2021 | | Efficacy and safety of mepolizumab in korean patients with severe eosinophilic asthma from the dream and mensa studies | 박해심 |
| 2017 | | Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria | 박해심, 예영민 |
| 2018 | | Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites | 박해심, 신유섭, 예영민 |
| 2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
| 2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
| 2020 | | Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma | 박해심 |
| 2019 | | Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications | 김승현, 박해심, 신승수, 신유섭, 예영민, 이소희, 정윤정 |
